Wave Life Sciences (WVE) SEC Filings: History & Chart

Wave Life Sciences Ltd.(WVE)

Biotechnology · Cambridge, MA

$3.52-0.23 (-6.13%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Wave Life Sciences Ltd.

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of liver disease; WVE-N531, an exon splicing oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington’s disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.

Cambridge, MA

317 employees

wavelifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Paul Bolno

View full financials

Form	Filing Date	Accepted	Document
EFFECT	Aug 14, 2026	Aug 17, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
4	Aug 13, 2026	Aug 13, 2026	View filing
SC 13D/A	Aug 11, 2026	Aug 11, 2026	View filing
15-12G	Aug 10, 2026	Aug 7, 2026	View filing
POS AM	Aug 10, 2026	Aug 7, 2026	View filing
POSASR	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
S-8 POS	Aug 10, 2026	Aug 7, 2026	View filing
8-K12B	Aug 7, 2026	Aug 7, 2026	View filing
10-Q	Jul 30, 2026	Jul 30, 2026	View filing
8-K	Jul 30, 2026	Jul 30, 2026	View filing
8-K	Jun 26, 2026	Jun 26, 2026	View filing
8-K	May 18, 2026	May 18, 2026	View filing

SEC Filings

Recent Filings